Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients

Abdishakur Abdulle, Michael P.T. Gillett, Samra Abouchacra, Sufyan M. Sabri, Mona Al Rukhaimi, Enyioma N. Obineche, Jaipaul Singh

Research output: Contribution to journalArticle

Abstract

Cardiovascular diseases (CVD) constitute a significant risk and may, in part, explain the high morbidity and mortality rates among haemodialysis (HD) patients. Several studies have implicated reduced insulin like growth factor (IGF-1) levels in the development of CVD. However, it is not clear whether IGF-1, and its relationship with other hormones such as leptin, insulin, and growth hormone (GH), as well as anthropometric variables may explain the high incidence of vascular complications in chronic kidney disease (CKD) patients. This study was designed to measure total serum IGF-1, leptin, insulin and GH levels in CKD patients and in age-matched control subjects and to elucidate the relationship between IGF-1 and GH, leptin, and insulin as well as other known aetiological risk factors for CVD including blood pressure, body mass index (BMI), and age. The study consisted of 50 CKD patients [36 M and 14 F; mean age; 41.8 ± 10.3 years) on maintenance haemodialysis and 50 healthy control subjects (36 M and 14 F; mean age 41.6 ± 10.2 years) matched for age and sex. None of the subject among patients and controls reported either smoking or history of diabetes mellitus. The circulating levels of IGF-1 were significantly lower (P < 0.001) in both male and female patients compared to the control subjects. Moreover, IGF-1 was strongly and inversely correlated with both systolic blood pressure (SBP) (r = -0.360; P < 0.01) and diastolic blood pressure (DBP) (r = -0.512; P < 0.001) in the CKD group, and when the two groups were combined SBP (r = -0.396; P < 0.001) and DBP (r = -0.296; P < 0.01). When adjusted for age, the correlation was more significant, however, when adjusted for BMI no significant correlation was observed between IGF-1 and blood pressure. IGF-1 was inversely correlated with age (r = -0.367; P < 0.01) and BMI (r = -0.310; P < 0.05) in the control group, but not the patient group. In controls and patients, respectively, a positive correlation between leptin and BMI (r = 0.358; P < 0.01; r = 0.640, P < 0.001) was observed. The results show that circulating levels of IGF-1 were significantly lower in CKD patients as compared to healthy normal subjects and were inversely correlated with SBP and DBP independent of age, but not BMI indicative of a strong relationship between cardiovascular risk factors and low IGF-1 levels. Although, the data do not clearly indicate low IGF-1 levels as a cause or an effect of these cardiovascular risk factors, they do point to an interesting relationship between low IGF-1 levels and increased cardiovascular risk factors among CKD patients as compared to age-matched healthy control subjects.

Original languageEnglish (US)
Pages (from-to)195-201
Number of pages7
JournalMolecular and Cellular Biochemistry
Volume302
Issue number1-2
DOIs
StatePublished - Aug 1 2007

Fingerprint

Insulin-Like Growth Factor I
Renal Dialysis
Blood pressure
Blood Pressure
Chronic Renal Insufficiency
Leptin
Body Mass Index
Growth Hormone
Healthy Volunteers
Insulin
Cardiovascular Diseases
Somatomedins
Medical problems
Blood Vessels
Diabetes Mellitus
Hormones
Smoking
Maintenance

Keywords

  • Blood pressure
  • Cardiovascular risk factors
  • Chronic kidney disease
  • IGF-1
  • Insulin like growth factor-1
  • United Arab Emirates

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Abdulle, A., Gillett, M. P. T., Abouchacra, S., Sabri, S. M., Rukhaimi, M. A., Obineche, E. N., & Singh, J. (2007). Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients. Molecular and Cellular Biochemistry, 302(1-2), 195-201. https://doi.org/10.1007/s11010-007-9441-6

Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients. / Abdulle, Abdishakur; Gillett, Michael P.T.; Abouchacra, Samra; Sabri, Sufyan M.; Rukhaimi, Mona Al; Obineche, Enyioma N.; Singh, Jaipaul.

In: Molecular and Cellular Biochemistry, Vol. 302, No. 1-2, 01.08.2007, p. 195-201.

Research output: Contribution to journalArticle

Abdulle, A, Gillett, MPT, Abouchacra, S, Sabri, SM, Rukhaimi, MA, Obineche, EN & Singh, J 2007, 'Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients', Molecular and Cellular Biochemistry, vol. 302, no. 1-2, pp. 195-201. https://doi.org/10.1007/s11010-007-9441-6
Abdulle, Abdishakur ; Gillett, Michael P.T. ; Abouchacra, Samra ; Sabri, Sufyan M. ; Rukhaimi, Mona Al ; Obineche, Enyioma N. ; Singh, Jaipaul. / Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients. In: Molecular and Cellular Biochemistry. 2007 ; Vol. 302, No. 1-2. pp. 195-201.
@article{d478e7711fab41ad82f0ba7bdae7bd5d,
title = "Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients",
abstract = "Cardiovascular diseases (CVD) constitute a significant risk and may, in part, explain the high morbidity and mortality rates among haemodialysis (HD) patients. Several studies have implicated reduced insulin like growth factor (IGF-1) levels in the development of CVD. However, it is not clear whether IGF-1, and its relationship with other hormones such as leptin, insulin, and growth hormone (GH), as well as anthropometric variables may explain the high incidence of vascular complications in chronic kidney disease (CKD) patients. This study was designed to measure total serum IGF-1, leptin, insulin and GH levels in CKD patients and in age-matched control subjects and to elucidate the relationship between IGF-1 and GH, leptin, and insulin as well as other known aetiological risk factors for CVD including blood pressure, body mass index (BMI), and age. The study consisted of 50 CKD patients [36 M and 14 F; mean age; 41.8 ± 10.3 years) on maintenance haemodialysis and 50 healthy control subjects (36 M and 14 F; mean age 41.6 ± 10.2 years) matched for age and sex. None of the subject among patients and controls reported either smoking or history of diabetes mellitus. The circulating levels of IGF-1 were significantly lower (P < 0.001) in both male and female patients compared to the control subjects. Moreover, IGF-1 was strongly and inversely correlated with both systolic blood pressure (SBP) (r = -0.360; P < 0.01) and diastolic blood pressure (DBP) (r = -0.512; P < 0.001) in the CKD group, and when the two groups were combined SBP (r = -0.396; P < 0.001) and DBP (r = -0.296; P < 0.01). When adjusted for age, the correlation was more significant, however, when adjusted for BMI no significant correlation was observed between IGF-1 and blood pressure. IGF-1 was inversely correlated with age (r = -0.367; P < 0.01) and BMI (r = -0.310; P < 0.05) in the control group, but not the patient group. In controls and patients, respectively, a positive correlation between leptin and BMI (r = 0.358; P < 0.01; r = 0.640, P < 0.001) was observed. The results show that circulating levels of IGF-1 were significantly lower in CKD patients as compared to healthy normal subjects and were inversely correlated with SBP and DBP independent of age, but not BMI indicative of a strong relationship between cardiovascular risk factors and low IGF-1 levels. Although, the data do not clearly indicate low IGF-1 levels as a cause or an effect of these cardiovascular risk factors, they do point to an interesting relationship between low IGF-1 levels and increased cardiovascular risk factors among CKD patients as compared to age-matched healthy control subjects.",
keywords = "Blood pressure, Cardiovascular risk factors, Chronic kidney disease, IGF-1, Insulin like growth factor-1, United Arab Emirates",
author = "Abdishakur Abdulle and Gillett, {Michael P.T.} and Samra Abouchacra and Sabri, {Sufyan M.} and Rukhaimi, {Mona Al} and Obineche, {Enyioma N.} and Jaipaul Singh",
year = "2007",
month = "8",
day = "1",
doi = "10.1007/s11010-007-9441-6",
language = "English (US)",
volume = "302",
pages = "195--201",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients

AU - Abdulle, Abdishakur

AU - Gillett, Michael P.T.

AU - Abouchacra, Samra

AU - Sabri, Sufyan M.

AU - Rukhaimi, Mona Al

AU - Obineche, Enyioma N.

AU - Singh, Jaipaul

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Cardiovascular diseases (CVD) constitute a significant risk and may, in part, explain the high morbidity and mortality rates among haemodialysis (HD) patients. Several studies have implicated reduced insulin like growth factor (IGF-1) levels in the development of CVD. However, it is not clear whether IGF-1, and its relationship with other hormones such as leptin, insulin, and growth hormone (GH), as well as anthropometric variables may explain the high incidence of vascular complications in chronic kidney disease (CKD) patients. This study was designed to measure total serum IGF-1, leptin, insulin and GH levels in CKD patients and in age-matched control subjects and to elucidate the relationship between IGF-1 and GH, leptin, and insulin as well as other known aetiological risk factors for CVD including blood pressure, body mass index (BMI), and age. The study consisted of 50 CKD patients [36 M and 14 F; mean age; 41.8 ± 10.3 years) on maintenance haemodialysis and 50 healthy control subjects (36 M and 14 F; mean age 41.6 ± 10.2 years) matched for age and sex. None of the subject among patients and controls reported either smoking or history of diabetes mellitus. The circulating levels of IGF-1 were significantly lower (P < 0.001) in both male and female patients compared to the control subjects. Moreover, IGF-1 was strongly and inversely correlated with both systolic blood pressure (SBP) (r = -0.360; P < 0.01) and diastolic blood pressure (DBP) (r = -0.512; P < 0.001) in the CKD group, and when the two groups were combined SBP (r = -0.396; P < 0.001) and DBP (r = -0.296; P < 0.01). When adjusted for age, the correlation was more significant, however, when adjusted for BMI no significant correlation was observed between IGF-1 and blood pressure. IGF-1 was inversely correlated with age (r = -0.367; P < 0.01) and BMI (r = -0.310; P < 0.05) in the control group, but not the patient group. In controls and patients, respectively, a positive correlation between leptin and BMI (r = 0.358; P < 0.01; r = 0.640, P < 0.001) was observed. The results show that circulating levels of IGF-1 were significantly lower in CKD patients as compared to healthy normal subjects and were inversely correlated with SBP and DBP independent of age, but not BMI indicative of a strong relationship between cardiovascular risk factors and low IGF-1 levels. Although, the data do not clearly indicate low IGF-1 levels as a cause or an effect of these cardiovascular risk factors, they do point to an interesting relationship between low IGF-1 levels and increased cardiovascular risk factors among CKD patients as compared to age-matched healthy control subjects.

AB - Cardiovascular diseases (CVD) constitute a significant risk and may, in part, explain the high morbidity and mortality rates among haemodialysis (HD) patients. Several studies have implicated reduced insulin like growth factor (IGF-1) levels in the development of CVD. However, it is not clear whether IGF-1, and its relationship with other hormones such as leptin, insulin, and growth hormone (GH), as well as anthropometric variables may explain the high incidence of vascular complications in chronic kidney disease (CKD) patients. This study was designed to measure total serum IGF-1, leptin, insulin and GH levels in CKD patients and in age-matched control subjects and to elucidate the relationship between IGF-1 and GH, leptin, and insulin as well as other known aetiological risk factors for CVD including blood pressure, body mass index (BMI), and age. The study consisted of 50 CKD patients [36 M and 14 F; mean age; 41.8 ± 10.3 years) on maintenance haemodialysis and 50 healthy control subjects (36 M and 14 F; mean age 41.6 ± 10.2 years) matched for age and sex. None of the subject among patients and controls reported either smoking or history of diabetes mellitus. The circulating levels of IGF-1 were significantly lower (P < 0.001) in both male and female patients compared to the control subjects. Moreover, IGF-1 was strongly and inversely correlated with both systolic blood pressure (SBP) (r = -0.360; P < 0.01) and diastolic blood pressure (DBP) (r = -0.512; P < 0.001) in the CKD group, and when the two groups were combined SBP (r = -0.396; P < 0.001) and DBP (r = -0.296; P < 0.01). When adjusted for age, the correlation was more significant, however, when adjusted for BMI no significant correlation was observed between IGF-1 and blood pressure. IGF-1 was inversely correlated with age (r = -0.367; P < 0.01) and BMI (r = -0.310; P < 0.05) in the control group, but not the patient group. In controls and patients, respectively, a positive correlation between leptin and BMI (r = 0.358; P < 0.01; r = 0.640, P < 0.001) was observed. The results show that circulating levels of IGF-1 were significantly lower in CKD patients as compared to healthy normal subjects and were inversely correlated with SBP and DBP independent of age, but not BMI indicative of a strong relationship between cardiovascular risk factors and low IGF-1 levels. Although, the data do not clearly indicate low IGF-1 levels as a cause or an effect of these cardiovascular risk factors, they do point to an interesting relationship between low IGF-1 levels and increased cardiovascular risk factors among CKD patients as compared to age-matched healthy control subjects.

KW - Blood pressure

KW - Cardiovascular risk factors

KW - Chronic kidney disease

KW - IGF-1

KW - Insulin like growth factor-1

KW - United Arab Emirates

UR - http://www.scopus.com/inward/record.url?scp=34547632565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547632565&partnerID=8YFLogxK

U2 - 10.1007/s11010-007-9441-6

DO - 10.1007/s11010-007-9441-6

M3 - Article

C2 - 17387582

AN - SCOPUS:34547632565

VL - 302

SP - 195

EP - 201

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -